MedTrace Logo

Evaluation of the Violence Prevention Initiative TERMA in Forensic Psychiatric Inpatient Care

NCT05932108 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-07-11

No results posted yet for this study

Summary

The aim of this project is to evaluate the violence prevention method Therapeutic meeting with aggression (TERMA) regarding adverse events and perceived safety by patients and staff within forensic psychiatric inpatient care. Additionally, the project will investigate whether the organizational culture influences the implementation of the TERMA method and the experiences of patients and staff in situations involving threats, violence, and the use of coercive measures.

Conditions

  • Forensic Nursing
  • Forensic Psychiatry

Interventions

BEHAVIORAL

Education in TERMA

Education of staff in TERMA. The primary aim of TERMA is to prevent aggression and violence through a system of low-effective treatment that is divided into escalating levels based on the patient's aggression level, risk of violence, and acts of violence . The TERMA model focuses on treatment, communication, and management of compassionate healthcare in forensic psychiatric settings . The levels of the TERMA model are in a "cascading" order, whereby if the treatment and management of one level are ineffective, the next level is initiated, and so on. The primary level involves the daily behavior and health status of the patient. The secondary level involves risk assessment and violence management, with a focus on creating an understanding of the situation for both the patient and healthcare workers. The tertiary level is utilized when violence cannot be avoided . Each level corresponds to a specific response according to the demands of the situation and environment.

OTHER

Changed work routines based on TERMA

NO planned intervention but staff work routines and behavior may change after their education in TERMA. Patients are exposed to these changes.

Sponsors & Collaborators

  • Vastra Gotaland Region

    lead OTHER_GOV

Principal Investigators

  • Sara Wallström, PhD · Västra Götalandsregionen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-15
Primary Completion
2024-02-25
Completion
2024-09-25

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05932108 on ClinicalTrials.gov